UCSF Helen Diller Family Comprehensive Cancer Center
member announcement 4/19/2018
[ view online ]

Funding and Award Deadlines

  • Apr 23: Pfizer-CTI RFA [application template]
    For over five years, UCSF scientists and Pfizer CTI have been working together to translate laboratory discoveries into novel therapeutics. Two funding types are available for collaboration: (1) Early proof-of-concept funding and (2) Multi-year joint programs (up to five years) to discover new therapeutics.
  • Apr 29: Phi Beta Psi Sorority Cancer Research Program (LSO)
    This program aims to to advance cancer research nationwide to improve prevention, diagnosis and treatment by providing research grants to qualified investigators addressing original questions and hypotheses to be explored in basic and clinical studies in the field of cancer.
  • May 7: Calico Cancer Research RFA
    Calico's oncology group is seeking opportunities for sponsored research or collaboration within the labs of outstanding academic investigators who are pursuing cancer-relevant science in areas of mutual interest.
  • May 8: Breast Cancer Research RFA
    Innovative proposals are invited that will make a major impact on breast cancer. Areas of interest include new treatment strategies and approaches to overcoming drug resistance but other innovative and high-risk approaches that may improve outcomes will also be considered.
  • Jun 4: The Mark Foundation for Cancer Research - Emerging Leader Awards
    These signature three-year academic grants totaling $750,000 will provide support to early career investigators conducting high-risk, high-impact cancer research. Eligible applicants must be within 3 - 8 years from the start of their independent research appointment.

View more funding opportunities

Program Meetings and Events

Other Conferences and Retreats

  • Jul 22-26: Molecular Therapeutics of Cancer Research Conference
    This conference will be held at the Sundance Mountain Resort in Utah and will cover a wide range of cancer-relevant topics including: (1) Disease areas such as sarcoma, lung cancer and leukemia; (2) Interesting drug targets including RAS and MCL1; (3) New aspects of immuno-oncology and (4) Opportunities for partnerships in academic and private sector drug discovery. Proudly sponsored by the Cancer Molecular Therapeutics Research Association and Huntsman Cancer Institute.
  • Sep 28-30: 2018 CREDITS Team Science Retreat [Application deadline: May 25]
    Faculty, researchers, and post-doctoral scholars from UC are invited to apply to attend the 2018 CREDITS Team Science Retreat, to be held at the UCLA Lake Arrowhead Conference Center. This program is funded by the NSF, the Elsevier Foundation, and the UC Office of the President.

UCSF-HDFCCC Erin Hayes, Communications
415.476.5445 (voice) | communications@cc.ucsf.edu